These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26216045)

  • 1. Murine pattern recognition receptor dectin-1 is essential in the development of experimental autoimmune uveoretinitis.
    Stoppelkamp S; Reid DM; Yeoh J; Taylor J; McKenzie EJ; Brown GD; Gordon S; Forrester JV; Wong SY
    Mol Immunol; 2015 Oct; 67(2 Pt B):398-406. PubMed ID: 26216045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye.
    Lee EJ; Brown BR; Vance EE; Snow PE; Silver PB; Heinrichs D; Lin X; Iwakura Y; Wells CA; Caspi RR; Rosenzweig HL
    J Immunol; 2016 Apr; 196(7):3148-58. PubMed ID: 26921309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism.
    Brown BR; Lee EJ; Snow PE; Vance EE; Iwakura Y; Ohno N; Miura N; Lin X; Brown GD; Wells CA; Smith JR; Caspi RR; Rosenzweig HL
    Clin Exp Immunol; 2017 Dec; 190(3):293-303. PubMed ID: 28763100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
    Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
    Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
    Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
    Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
    Escobar T; Yu CR; Muljo SA; Egwuagu CE
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Udaka K; Ueno H
    Immunogenetics; 2005 Jun; 57(5):337-43. PubMed ID: 15902435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
    Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual stimulation and brain-derived neurotrophic factor (BDNF) have protective effects in experimental autoimmune uveoretinitis.
    Zloh M; Kutilek P; Hejda J; Fiserova I; Kubovciak J; Murakami M; Stofkova A
    Life Sci; 2024 Oct; 355():122996. PubMed ID: 39173995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
    Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-like iPS-derived Suppressor Cells Reduce Th1-mediated Immune Response to a Retinal Antigen.
    Hase K; Namba K; Wada H; Tsuji H; Maeda A; Murata T; Otsuka R; Iwata D; Kanda A; Noda K; Kitaichi N; Seino KI; Ishida S
    Curr Eye Res; 2021 Dec; 46(12):1908-1916. PubMed ID: 34260333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells.
    Li X; Gao Q; Yang L; Han M; Zhou C; Mu H
    J Neuroimmunol; 2020 Aug; 345():577286. PubMed ID: 32559555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.
    Xing L; Yang P; Wu C; Jin H; Chen X; Gao Y; Li B; Huang X; Zhou H
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1650-8. PubMed ID: 16601981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.